Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ulrike Rauh

1PUBLICATIONS

6CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Aug 23, 2024

BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models.

Ulrike Rauh, Guo Wei, Michael Serrano-Wu

Pageof 1

Frequent Collaborators

1 joint publications

Christopher T Lemke

1 joint publications

Sabine Pilari

1 joint publications

Matthias Ocker

1 joint publications

Jennifer Roth

1 joint publications

Douglas Daniels

1 joint publications

Todd R Golub

Frequent Collaborators

1 joint publications

Christopher T Lemke

1 joint publications

Sabine Pilari

1 joint publications

Matthias Ocker

1 joint publications

Jennifer Roth

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos

Top Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

See more related videos